- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06905470
Les effets de l'excentrique par rapport à l'entraînement en force standard dans la réhabilitation primaire des lésions de la moelle épinière (KREHA3)
Les effets de l'excentrique par rapport à l'entraînement en force standard dans la réhabilitation primaire des lésions de la moelle épinière - un essai contrôlé randomisé à paire appariée
The goal of this clinical trial is to assess the effects of eccentric arm-crank (KREHA) training compared to standard clinical routine strength (STAN) training in individuals undergoing primary spinal cord injury (SCI) rehabilitation.
The main questions this trail aims to answer are:
- what are the effects of the training on upper body strength, aerobic performance, muscle volume, functional independence, and health-related quality of life?
- is the KREHA training feasible to implement into the rehabilitation routine?
Participants will:
- perform either 20 KREHA sessions or 20 STAN sessions within 12 weeks
- perform a test battery to collect data on training effects before (pretest) and after (posttest) the study intervention
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Fabian Ammann, MSc
- Numéro de téléphone: +41419396624
- E-mail: fabian.ammann@paraplegie.ch
Sauvegarde des contacts de l'étude
- Nom: Anneke Hertig-Godeschalk, PhD
- Numéro de téléphone: +414 9396603
- E-mail: anneke.hertig@paraplegie.ch
Lieux d'étude
-
-
Canton of Lucerne
-
Nottwil, Canton of Lucerne, Suisse, 6207
- Swiss Paraplegic Centre
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- 18 years or older.
- informed consent as confirmed per signature.
- traumatic or disease-related SCI.
- participating in the routine strength training program during primary SCI rehabilitation at the study center (generally this is initiated around one month after SCI onset).
- wheelchair dependency during activities of daily living, defined by a score of 0-2 in the SCIM subsection regarding "Mobility in the house".
- passed sports medical assessment and having sufficient biceps/triceps function to perform arm-crank training, as determined by an experienced sports medicine physician
Exclusion Criteria:
- inflammatory or neurodegenerative diseases (including multiple sclerosis or Guillain-Barré syndrome).
- comorbidities or other health issues that may interfere with study participation, inability or contraindications to undergo the investigated intervention.
- MRI contraindications (magnetic metal parts or electronic implants such as pacemakers in the body).
- pregnancy (anamnestic).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Eccentric arm-crank (KREHA) training
The eccentric training intervention consists of 20 training sessions performed on a symmetric arm-crank (Krafttraining mittels exzentrischer Handkurbel, KREHA) device. The training sessions have a duration of approximately 30 min and will be completed within twelve weeks, with a maximum of three sessions per week. |
20 eccentric resistance training sessions will be performed on a symmetric arm-crank ergometer in a supine position. |
|
Comparateur actif: Standard clinical routine strength (STAN) training
The standard strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. The training sessions have a duration of approximately 60 min and will be completed within twelve weeks, with around three sessions per week. |
The regular strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Upper body strength
Délai: < 1 week pre and 12 weeks post intervention start.
|
Change in upper body strength will be measured by a one-repetition maximum (1RM) bench press (in kg). The maximum amount of weight that can be pushed upwards for one repetition, while lying in a supine position on a weight training bench. |
< 1 week pre and 12 weeks post intervention start.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Upper body strength
Délai: < 1 week pre and 12 weeks post intervention start.
|
Change in upper body strength measured by a 1RM bench pull (in kg). The maximum amount of weight that can be pulled upwards for one repetition, while lying in a prone position on a weight training bench. |
< 1 week pre and 12 weeks post intervention start.
|
|
Handgrip strength
Délai: < 1 week pre and 12 weeks post intervention start.
|
Change in maximum strength of three handgrip measurements (in kg) of both hands using a Jamar Handgrip Dynamometer. |
< 1 week pre and 12 weeks post intervention start.
|
|
Aerobic performance
Délai: < 1 week pre and 12 weeks post intervention start.
|
Change in cardiopulmonary adaptations, measured by aerobic performance in an exercise test on a regular arm-crank ergometer. A ramp protocol starting at 20 Watt followed by 1 Watt / 6 sec increments to failure will be used. The following parameters will be evaluated during this aerobic endurance test: power at failure at the end of the test (in Watt), peak oxygen uptake during the test (in ml/kg/min), maximal heart rate (bpm) |
< 1 week pre and 12 weeks post intervention start.
|
|
Muscle volume
Délai: < 1 week pre and 12 weeks post intervention start.
|
Magnetic resonance imaging (MRI) of relevant upper body muscles of the dominant upper arm and shoulder will be used to measure change in muscle volume. |
< 1 week pre and 12 weeks post intervention start.
|
|
Arm circumference
Délai: < 1 week pre and 12 weeks post intervention start.
|
Change in arm circumference of the right and left lower and upper arm (in cm), will be used to estimate muscle volume. |
< 1 week pre and 12 weeks post intervention start.
|
|
Functioning during activities of daily living
Délai: < 1 week pre and 12 weeks post intervention start.
|
Change in functioning during activities of daily living will be assessed by the Spinal Cord Independence Measure (SCIM) as extracted from clinical records. The SCIM total score ranges from 0-100, with higher scores indicating higher levels of functional independence. |
< 1 week pre and 12 weeks post intervention start.
|
|
Health-related quality of life
Délai: < 1 week pre and 12 weeks post intervention start.
|
Change in health-related quality of life will be assessed using the Short Form Health Survey (SF-12). Weighted physical and mental component scores range from 0-100, with higher scores indicating better physical or mental health. |
< 1 week pre and 12 weeks post intervention start.
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Feasibility of the KREHA training (total number of training sessions)
Délai: Throughout the intervention phase, week 0-12
|
Successful implementation of the KREHA training in the clinical routine, by assessing whether the 20 KREHA sessions are completed within 12 weeks. |
Throughout the intervention phase, week 0-12
|
|
Feasibility of the KREHA training progression (number of sessions adapted)
Délai: Throughout the intervention phase, week 0-12
|
Feasibility of the KREHA training progression, by assessing how many training sessions needed to be adapted. |
Throughout the intervention phase, week 0-12
|
|
Feasibility of the KREHA training progression (power adaptation)
Délai: Throughout the intervention phase, week 0-12
|
Feasibility of the KREHA training progression, by assessing how much the target power (in Watts) of a training session needed to be adapted compared to the initially planned progression. |
Throughout the intervention phase, week 0-12
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2023-21
- SNCTP000006132 (Autre identifiant: Swiss National Clinical Trials Portal)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .